Cargando…

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

BACKGROUND: Despite a lack of clinical evidence, hydroxychloroquine and azithromycin are being administered widely to patients with verified or suspected coronavirus disease 2019 (COVID‐19). Both drugs may increase risk of lethal arrhythmias associated with QT interval prolongation. METHODS AND RESU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramireddy, Archana, Chugh, Harpriya, Reinier, Kyndaron, Ebinger, Joseph, Park, Eunice, Thompson, Michael, Cingolani, Eugenio, Cheng, Susan, Marban, Eduardo, Albert, Christine M., Chugh, Sumeet S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429030/ https://www.ncbi.nlm.nih.gov/pubmed/32463348 http://dx.doi.org/10.1161/JAHA.120.017144

Ejemplares similares

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Ethnicity and sudden cardiac death: Why are some at risk and others protected?
por: Reinier, Kyndaron, et al.
Publicado: (2022)

Ischemic Heart Disease Diagnosed Before Sudden Cardiac Arrest Is Independently Associated With Improved Survival
por: Stecker, Eric C., et al.
Publicado: (2014)

High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study
por: Yuan, Neal, et al.
Publicado: (2023)

Out-of-Hospital Cardiac Arrest Response and Outcomes During the COVID-19 Pandemic
por: Uy-Evanado, Audrey, et al.
Publicado: (2021)

PO-701-02 SUDDEN CARDIAC ARREST DURING THE COVID-19 PANDEMIC IN HISPANIC AND NON-HISPANIC RESIDENTS OF A WEST COAST COUNTY
por: Chugh, Harpriya, et al.
Publicado: (2022)

QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019
por: Tuncer, Tunc, et al.
Publicado: (2020)

QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
por: Sridhar, Arun R., et al.
Publicado: (2020)

Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
por: Nichols, Gregory A., et al.
Publicado: (2009)

Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States
por: Cho, Jae Hyung, et al.
Publicado: (2020)

System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)

THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ON THE CORRECTED QT INTERVAL IN PATIENTS WITH COVID-19
por: Batemarco, Thomas, et al.
Publicado: (2022)

TCT CONNECT-217 Hydroxychloroquine and Azithromycin Usage in African American Patients With Coronavirus Disease 2019 (COVID-19) and Their Effects on QT Interval
por: Al-Sadawi, Mohammed, et al.
Publicado: (2020)

Occupation and risk of sudden death in a United States community: a case–control analysis
por: Zhang, Lin, et al.
Publicado: (2015)

Left Ventricular Diameter and Risk Stratification for Sudden Cardiac Death
por: Narayanan, Kumar, et al.
Publicado: (2014)

Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
por: Bernardini, Andrea, et al.
Publicado: (2021)

Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19
por: Echarte-Morales, Julio, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

B-PO01-089 SUDDEN CARDIAC ARREST DURING THE COVID-19 PANDEMIC: SIGNIFICANT EFFECTS ON INCIDENCE AND OUTCOMES
por: Chugh, Harpriya, et al.
Publicado: (2021)

Evaluation of Sudden Cardiac Arrest by Race/Ethnicity Among Residents of Ventura County, California, 2015-2020
por: Reinier, Kyndaron, et al.
Publicado: (2021)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection
por: Voisin, Olivier, et al.
Publicado: (2020)

Sudden cardiac arrest during the COVID-19 pandemic: A two-year prospective evaluation in a North American community
por: Chugh, Harpriya S., et al.
Publicado: (2023)

Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin
por: Cipriani, Alberto, et al.
Publicado: (2020)

Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients
por: Eftekhar, Seyed Parsa, et al.
Publicado: (2021)

Effects of hydroxychloroquine treatment on QT interval
por: Hooks, Matthew, et al.
Publicado: (2020)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

Azithromycin: QT interval prolongation: case report
Publicado: (2021)

The effect of 5-day course of hydroxychloroquine and azithromycin combination on QT interval in non-ICU COVID19(+) patients
por: Bakhshaliyev, Nijad, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Lengthening of the QT interval, bradycardia and atrioventricular block following an off-label use: case report
Publicado: (2020)

Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection
por: Moschini, Luigi, et al.
Publicado: (2020)

QT interval monitoring for inpatient treated with hydroxychloroquine/azithromycin association in the context of SARS-CoV-2 pandemic
por: Bun, S., et al.
Publicado: (2021)

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)

Health Insurance Expansion and Incidence of Out‐of‐Hospital Cardiac Arrest: A Pilot Study in a US Metropolitan Community
por: Stecker, Eric C., et al.
Publicado: (2017)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ta4ag43pilvit1e1l0cd6suqed